vs
ARROWHEAD PHARMACEUTICALS, INC.（ARWR）与世纪互联（VNET）财务数据对比。点击上方公司名可切换其他公司
世纪互联的季度营收约是ARROWHEAD PHARMACEUTICALS, INC.的1.4倍（$362.7M vs $264.0M），ARROWHEAD PHARMACEUTICALS, INC.净利率更高（11.7% vs -10.7%，领先22.3%），ARROWHEAD PHARMACEUTICALS, INC.自由现金流更多（$11.3M vs $-193.1M）
Arrowhead Pharmaceuticals是总部位于美国加利福尼亚州帕萨迪纳的上市生物制药企业，专注于通过RNA干扰（RNAi）作用机制开发创新药物，核心研发管线覆盖乙型肝炎、α-1抗胰蛋白酶缺陷相关肝病及心血管疾病的治疗领域。
VNET Group即世纪互联，是中国领先的第三方中立数据中心服务商，提供机柜托管、云基础设施、混合云部署及网络管理等解决方案，服务覆盖科技、金融、零售等多领域企业客户，为企业数字化运营提供稳定的算力与网络支撑。
ARWR vs VNET — 直观对比
营收规模更大
VNET
是对方的1.4倍
$264.0M
净利率更高
ARWR
高出22.3%
-10.7%
自由现金流更多
ARWR
多$204.4M
$-193.1M
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $264.0M | $362.7M |
| 净利润 | $30.8M | $-38.7M |
| 毛利率 | — | 20.9% |
| 营业利润率 | 15.5% | 0.5% |
| 净利率 | 11.7% | -10.7% |
| 营收同比 | 10461.3% | — |
| 净利润同比 | 117.8% | — |
| 每股收益（稀释后） | $0.22 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARWRVNET
| Q4 25 | $264.0M | — | ||
| Q3 25 | — | $362.7M | ||
| Q1 25 | — | $309.5M | ||
| Q3 24 | — | $302.2M | ||
| Q2 24 | — | $274.4M | ||
| Q1 24 | — | $262.9M | ||
| Q3 23 | — | $258.6M | ||
| Q2 23 | — | $251.2M |
净利润ARWRVNET
| Q4 25 | $30.8M | — | ||
| Q3 25 | — | $-38.7M | ||
| Q1 25 | — | $-2.4M | ||
| Q3 24 | — | $-2.1M | ||
| Q2 24 | — | $-1.1M | ||
| Q1 24 | — | $-22.0M | ||
| Q3 23 | — | $-5.5M | ||
| Q2 23 | — | — |
毛利率ARWRVNET
| Q4 25 | — | — | ||
| Q3 25 | — | 20.9% | ||
| Q1 25 | — | 25.2% | ||
| Q3 24 | — | 23.2% | ||
| Q2 24 | — | 21.3% | ||
| Q1 24 | — | 21.6% | ||
| Q3 23 | — | 16.2% | ||
| Q2 23 | — | 18.8% |
营业利润率ARWRVNET
| Q4 25 | 15.5% | — | ||
| Q3 25 | — | 0.5% | ||
| Q1 25 | — | 0.1% | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.2% | ||
| Q3 23 | — | 1.7% | ||
| Q2 23 | — | 5.1% |
净利率ARWRVNET
| Q4 25 | 11.7% | — | ||
| Q3 25 | — | -10.7% | ||
| Q1 25 | — | -0.8% | ||
| Q3 24 | — | -0.7% | ||
| Q2 24 | — | -0.4% | ||
| Q1 24 | — | -8.4% | ||
| Q3 23 | — | -2.1% | ||
| Q2 23 | — | — |
每股收益（稀释后）ARWRVNET
| Q4 25 | $0.22 | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $715.0M | $492.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $568.4M | $890.8M |
| 总资产 | $1.6B | $6.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ARWRVNET
| Q4 25 | $715.0M | — | ||
| Q3 25 | — | $492.1M | ||
| Q1 25 | — | $544.3M | ||
| Q3 24 | — | $219.5M | ||
| Q2 24 | — | $247.2M | ||
| Q1 24 | — | $246.9M | ||
| Q3 23 | — | $370.4M | ||
| Q2 23 | — | $325.9M |
总债务ARWRVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
股东权益ARWRVNET
| Q4 25 | $568.4M | — | ||
| Q3 25 | — | $890.8M | ||
| Q1 25 | — | $927.8M | ||
| Q3 24 | — | $902.9M | ||
| Q2 24 | — | $900.6M | ||
| Q1 24 | — | $895.1M | ||
| Q3 23 | — | $942.7M | ||
| Q2 23 | — | $952.6M |
总资产ARWRVNET
| Q4 25 | $1.6B | — | ||
| Q3 25 | — | $6.1B | ||
| Q1 25 | — | $5.4B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.0B | ||
| Q1 24 | — | $3.9B | ||
| Q3 23 | — | $4.1B | ||
| Q2 23 | — | $4.0B |
负债/权益比ARWRVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 1.28× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.5M | $113.8M |
| 自由现金流经营现金流 - 资本支出 | $11.3M | $-193.1M |
| 自由现金流率自由现金流/营收 | 4.3% | -53.2% |
| 资本支出强度资本支出/营收 | 0.8% | 84.6% |
| 现金转化率经营现金流/净利润 | 0.44× | — |
| 过去12个月自由现金流最近4个季度 | — | $-589.7M |
8季度趋势，按日历期对齐
经营现金流ARWRVNET
| Q4 25 | $13.5M | — | ||
| Q3 25 | — | $113.8M | ||
| Q1 25 | — | $27.0M | ||
| Q3 24 | — | $108.3M | ||
| Q2 24 | — | $55.8M | ||
| Q1 24 | — | $37.1M | ||
| Q3 23 | — | $62.3M | ||
| Q2 23 | — | $58.4M |
自由现金流ARWRVNET
| Q4 25 | $11.3M | — | ||
| Q3 25 | — | $-193.1M | ||
| Q1 25 | — | $-220.0M | ||
| Q3 24 | — | $-95.0M | ||
| Q2 24 | — | $-81.6M | ||
| Q1 24 | — | $-102.2M | ||
| Q3 23 | — | $-67.5M | ||
| Q2 23 | — | $4.0M |
自由现金流率ARWRVNET
| Q4 25 | 4.3% | — | ||
| Q3 25 | — | -53.2% | ||
| Q1 25 | — | -71.1% | ||
| Q3 24 | — | -31.4% | ||
| Q2 24 | — | -29.8% | ||
| Q1 24 | — | -38.9% | ||
| Q3 23 | — | -26.1% | ||
| Q2 23 | — | 1.6% |
资本支出强度ARWRVNET
| Q4 25 | 0.8% | — | ||
| Q3 25 | — | 84.6% | ||
| Q1 25 | — | 79.8% | ||
| Q3 24 | — | 67.3% | ||
| Q2 24 | — | 50.1% | ||
| Q1 24 | — | 53.0% | ||
| Q3 23 | — | 50.2% | ||
| Q2 23 | — | 21.7% |
现金转化率ARWRVNET
| Q4 25 | 0.44× | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
